class GBMTreatmentFramework:
    """
    Framework synthesizing innovative GBM treatment approaches.
    Core principle: GBM requires simultaneous multi-vulnerability targeting
    with rational temporal sequencing and biomarker-guided personalization.
    """
    
    PILLAR_1_FOCUSED_ULTRAMETER_BBB = {
        'mechanism': 'Transient BBB disruption enabling enhanced drug delivery',
        'timing': 'Must precede therapeutic agent delivery by 1-4 hours',
        'enables': ['nanoparticle_delivery', 'antibody_penetration', 'CAR-T_trafficking', 'viral_vector_delivery'],
        'key_limitation': 'Repeated sessions needed; spatial coverage incomplete'
    }
    
    PILLAR_2_METABOLIC_TARGETING = {
        'glutamine_addiction': 'GLS inhibitors (CB-839/Telaglenastat) target glutaminolysis',
        'mitochondrial_OXPHOS': 'IACS-010759 targets electron transport chain',
        'glycolysis': '2-DG and LDH inhibitors target Warburg effect',
        'ketogenic_diet': 'Adjuvant metabolic stress to sensitize tumors',
        'optimal_timing': 'Metabolic priming before immune activation may sensitize T-cells'
    }
    
    PILLAR_3_IMMUNE_ACTIVATION = {
        'priming_phase': 'Oncolytic viruses (DNX-2401, G207) convert cold-to-hot tumor',
        'activation_phase': 'Checkpoint inhibitors (anti-PD-1) after immune priming',
        'cellular_therapy': 'CAR-T (EGFRvIII, IL13Rα2, HER2) with focused ultrasound delivery',
        'bispecific_engagers': 'Next-generation approach distinct from CAR-T',
        'vaccines': 'Neoantigen/mRNA vaccines for durable immunity'
    }
    
    RESISTANCE_MANAGEMENT = {
        'oncolytic_virus': 'Pre-existing immunity, antiviral response; solution: immunosuppressive carrier cells, serotype switching',
        'CAR_T': 'Antigen loss, T-cell exhaustion; solution: multi-antigen targeting, armored CAR-T, local delivery',
        'metabolic': 'Metabolic plasticity, compensatory pathways; solution: dual metabolic inhibitors, dietary adjuvants',
        'general': 'Glioma stem cell persistence; solution: differentiation therapy, stem cell-specific targeting'
    }
    
    BIOMARKER_GUIDANCE = {
        'ctDNA_circulating_tumor_DNA': 'Real-time treatment response and resistance monitoring',
        'metabolic_signatures': 'Glutamine/glucose flux predicts metabolic therapy susceptibility',
        'immune_profiling': 'T-cell infiltration and exhaustion markers guide immunotherapy timing',
        'spatial_transcriptomics': 'Maps intratumoral heterogeneity for combination design',
        'microbiome': 'Gut microbiome composition may predict immunotherapy response'
    }
    
    TEMPORAL_SEQUENCING_PROTOCOL = {
        'phase_1_days_1_3': 'Focused ultrasound BBB opening + metabolic priming',
        'phase_2_days_4_10': 'Oncolytic virus delivery + continued metabolic pressure',
        'phase_3_days_11_21': 'Immune activation (checkpoint inhibitors + vaccine boost)',
        'phase_4_maintenance': 'Metabolic maintenance + periodic BBB opening for CAR-T/vaccine boosters',
        'monitoring': 'ctDNA and imaging at each phase transition'
    }
    
    EMERGING_FRONTIERS = {
        'CRISPR_gene_editing': 'In vivo delivery via lipid nanoparticles; targeting MGMT, IDH, resistance genes',
        'microbiome_modulation': 'Gut-brain axis influences immunotherapy response; fecal transplant potential',
        'radiogenomics': 'Imaging-derived molecular profiling for non-invasive treatment selection',
        'organoid_testing': 'Patient-derived organoids for pre-clinical combination testing',
        'adaptive_trials': 'Bayesian designs (GBM AGILE) enabling rapid combination testing'
    }
    
    def get_personalized_recommendation(self, biomarker_profile):
        """Generate personalized combination based on biomarker data."""
        recommendations = []
        if biomarker_profile.get('MGMT_unmethylated'):
            recommendations.append('CRISPR-mediated MGMT silencing + alternative alkylating strategies')
        if biomarker_profile.get('high_glutamine_flux'):
            recommendations.append('GLS inhibitor + focused ultrasound enhanced delivery')
        if biomarker_profile.get('immune_cold'):
            recommendations.append('Oncolytic virus priming before checkpoint inhibition')
        if biomarker_profile.get('glioma_stem_cells_high'):
            recommendations.append('Differentiation therapy + stem cell metabolic targeting')
        return recommendations